Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA最新文献

{"title":"DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients.","authors":"Fengning Chuan, Mei Mei, Kun Liao, Xin Ye, Yinghao Li, Ying Li, Rong Li, Bo Zhou","doi":"10.1007/s00198-025-07644-5","DOIUrl":"https://doi.org/10.1007/s00198-025-07644-5","url":null,"abstract":"<p><p>This study develops a DXA-based radiomic model to predict fracture risk in elderly T2DM patients. The model, validated with AUCs up to 0.774, 0.759, and 0.739 for vertebral, hip, and major osteoporotic fractures respectively, offers a potential tool for personalized fracture risk assessment and management in clinical settings.</p><p><strong>Purpose: </strong>To develop and validate a novel radiomic model based on dual-energy X-ray absorptiometry (DXA) lumbar spine and hip images for predicting fracture risk in elderly type 2 diabetes mellitus (T2DM) patients.</p><p><strong>Methods: </strong>A training cohort of 294 elderly T2DM patients (October 2019 to August 2022) and a validation cohort from the ABCD cohort were utilized. Radiomics features were extracted from baseline DXA images, and a radiomics model was constructed using Cox proportional hazards regression. A user-friendly radiomics score (Radscore) was derived for practical application.</p><p><strong>Results: </strong>In the derivation set, 105 (35.7%) patients had radiographically confirmed vertebral fractures. In the validation set with a median 5-year follow-up, 3.2% experienced incident clinical vertebral fracture, 2.4% incident hip fracture, and 7.0% incident major osteoportic fractures (MOFs). Thirteen features were selected to develop the radiomics model. The AUC for predicting radiographically confirmed vertebral fracture in the derivation set was 0.830 (95% CI: 0.783-0.878). In the validation set, AUCs for predicting incident clinical vertebral fractures, hip fractures, and MOFs were 0.774 (95% CI: 0.686-0.862), 0.759 (95% CI: 0.645-0.873), and 0.739 (95% CI: 0.676-0.803), respectively. The Radscore exhibited weak correlations with traditional fracture assessment tools but independently with the diabetes-specific phenotype. It effectively stratified T2DM patients into risk groups with significantly differing fracture incidences.</p><p><strong>Conclusions: </strong>This DXA-based Radscore presented in this study offers a robust approach to stratify fracture risk in elderly patients with T2DM. Its potential integration into clinical settings could facilitate personalized management strategies aimed at reducing fracture incidence.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144747049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence of hip fractures in persons with and without Parkinson's disease in Finland: a 15-year longitudinal study.","authors":"Miriam T Y Leung, Marja-Leena Lamidi, Sirpa Hartikainen, Blair Rajamaki, J Simon Bell, Justin P Turner, Anna-Maija Tolppanen","doi":"10.1007/s00198-025-07632-9","DOIUrl":"https://doi.org/10.1007/s00198-025-07632-9","url":null,"abstract":"<p><p>Despite growing evidence on prodromal symptoms of Parkinson's disease, it remains unknown whether they culminated in clinically significant events. We found elevated risks of hip fractures from 3 years before until up to 10 years after diagnosis of Parkinson's disease, underscoring the need for early and continuous fracture risk management.</p><p><strong>Purpose: </strong>Parkinson's disease (PD) is associated with a higher risk of hip fracture. However, the risk of hip fracture at the prodromal stage of PD is unknown. Our study aimed to investigate the incidence of hip fractures in persons with and without PD in Finland from 5 years before to 10 years after the diagnosis of PD.</p><p><strong>Methods: </strong>We included persons diagnosed with PD between 2000 and 2009 in Finland and 1:2 matched comparison cohort. Hazard ratio [HR] was computed to assess overall risk of incident hip fracture. The annual incidence rate per 1000 person-year [IR/1000PY] and incidence rate ratios [IRR] were calculated for each year of follow-up from 5 years before to 10 years after PD diagnosis.</p><p><strong>Results: </strong>During the follow-up among 33,153 eligible persons, 13.4% persons with and 5.3% persons without PD had an incident hip fracture (HR 1.82, 95% confidence interval [CI] 1.47-2.26). Persons with PD had higher annual incidence rates of hip fracture starting from 3 years before diagnosis (with PD: IR/1000PY 2.83, 95% CI 1.93-4.02; without PD: IR/1000PY 1.64, 95% CI 1.15-2.28). The higher annual incidence rates continued until 10 years after diagnosis (with PD: IR/1000PY 15.7, 95% CI 11.7-20.5; without PD: IR/1000PY 4.53, 95% CI 3.08-6.44). Prevalence of fall-risk-increasing medications but not anti-osteoporosis medications was higher at hip fractures among persons with PD than without PD.</p><p><strong>Conclusion: </strong>As the risk of hip fracture is elevated already years before the diagnosis of PD, it is important to manage fall risks concomitantly while applying the diagnostic procedures for PD.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144736672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quantitative computed tomography provides improved accuracy for diagnosis of lumbar osteoporosis in patients with facet joint osteoarthritis: a cross-sectional study.","authors":"Xiayan Wang, Chenqing Ji, Shihuai Li, Kexin Wang, Meng He, Zehao Yu, Yuanzhi Weng, Weibo Jiang, Xiongfeng Tang, Deming Guo, Yanguo Qin","doi":"10.1007/s00198-025-07600-3","DOIUrl":"https://doi.org/10.1007/s00198-025-07600-3","url":null,"abstract":"<p><p>This study employed both QCT and DXA to assess BMD in the same cohort and investigated the influence of FJOA on BMD measurements and the detection rates of osteoporosis. The results indicate that QCT is more accurate for assessing regional BMD in patients with FJOA.</p><p><strong>Purpose: </strong>This study aimed to compare the detection rates of lumbar osteoporosis in patients with FJOA between QCT and DXA and to analyze the impact of FJOA on regional BMD measurement using each method.</p><p><strong>Methods: </strong>This single-center, retrospective, cross-sectional study included participants without a history of spinal instrumentation surgery, spinal fractures of > 2 levels, spinal tumors or infections, and sacralization of lumbar spine. The detection rates of lumbar osteoporosis between QCT and DXA in patients with FJOA were compared using McNemar's test. Associations between BMDs and FJOA severity were assessed using linear mixed models. Discordance in BMD classification between DXA and QCT was categorized as minor or major according to Woodson's definition.</p><p><strong>Results: </strong>The 219 study participants had a mean age of 65.0 ± 10.7 years and included 155 (70.8%) women. The rate of lumbar osteoporosis identification with QCT was noticeably greater than that with DXA (58% vs 34.2%, p < 0.0001). Severe FJOA was independently associated with lower vBMD (multivariable β =  - 4.23 (95% confidence interval (CI), - 7.68 to - 0.77); p = 0.17), while both slight-to-moderate and severe FJOA were independently associated with higher areal BMD (aBMD). With increasing FJOA severity, the aBMD measured by DXA also increased (slight-to-moderate, β = 0.31 (95% CI, 0.16-0.46), p < 0.001; severe FJOA, β = 1.03 (95% CI, 0.79-1.27), p < 0.001).</p><p><strong>Conclusions: </strong>More severe FJOA was associated with higher aBMD on DXA and a lower vBMD on QCT. Additionally, the rate of lumbar osteoporosis detection was significantly higher with QCT than with DXA. These findings indicate that QCT is more accurate for assessing regional BMD in patients with FJOA, supporting the need for caution when using DXA to evaluate BMD in clinical practice.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fatty acid dietary intakes and blood concentrations in relation to hip fracture risk in adults: a systematic review and meta-analysis of prospective cohort studies.","authors":"Sana Niazi, Maedeh Mazloomi, Afshin Ostovar, Noushin Fahimfar, Hamidreza Nematy, Masoud Rezaie, Feizollah Niazi, Farideh Doroodgar","doi":"10.1007/s00198-025-07587-x","DOIUrl":"https://doi.org/10.1007/s00198-025-07587-x","url":null,"abstract":"<p><p>Previous research suggests that dietary intake and blood levels of fatty acids may influence the risk of osteoporosis and hip fractures, although findings have been inconsistent. We conducted a meta-analysis of nine prospective cohort studies involving 382,094 participants and 12,392 hip fractures to investigate these associations. Follow-ups ranged from 7 to 24 years in duration. A hazard ratio (HR) of 1.20 (95% CI: 1.08-1.33) indicated that a higher intake of saturated fatty acids (SFAs) was associated with an increased risk of hip fractures. In contrast, polyunsaturated fatty acids (PUFAs) (HR: 0.93; 95% CI: 0.85-1.00) and linoleic acid (LA) (HR: 0.89; 95% CI: 0.82-0.96) were associated with a lower risk, though the PUFA association was marginal. The inverse relationship for LA was observed only at intakes of 9-16 g per day. Higher amounts of PUFAs (HR: 0.75; 95% CI: 0.61-0.92), total omega-3 fatty acids (HR: 0.79; 95% CI: 0.64-0.97), and eicosapentaenoic acid (EPA) (HR: 0.76; 95% CI: 0.62-0.94) in the blood were linked to a lower risk. No significant associations were found for other fatty acids. These findings suggest that consuming 9-16 g of linoleic acid (LA) daily (equivalent to 2-3 tablespoons of corn oil or 30-60 g of walnuts) and maintaining elevated blood levels of omega-3 fatty acids, especially eicosapentaenoic acid (EPA), may help reduce the risk of hip fractures.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Zoledronic acid-induced acute psychiatric disorder.","authors":"Ya-Jun Xiao, Yu-Yu Zhou, Yan-Qun Liu","doi":"10.1007/s00198-025-07638-3","DOIUrl":"https://doi.org/10.1007/s00198-025-07638-3","url":null,"abstract":"<p><p>As a bisphosphonate drug, zoledronic acid is widely used in the treatment of osteoporosis, hypercalcemia, Paget's disease, and solid malignant tumors. Common adverse reactions include acute-phase responses such as myalgia, fatigue, arthralgia, and fever, while psychiatric disorders have been infrequently reported. This paper presents a case of acute psychiatric disorder in an osteoporotic patient following intravenous infusion of zoledronic acid for the first time, underscoring the necessity of clinical vigilance regarding such rare adverse reactions during treatment.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study.","authors":"Min Young Chun, Jimin Jeon, Seok Jong Chung, Jinkwon Kim","doi":"10.1007/s00198-025-07611-0","DOIUrl":"https://doi.org/10.1007/s00198-025-07611-0","url":null,"abstract":"<p><p>Brief rationale: dementia and osteoporosis share risk factors and are rising in aging populations.</p><p><strong>Main results: </strong>osteoporosis significantly increases the risk of all-cause dementia, Alzheimer's disease dementia, and vascular dementia in Korean older women. Significance of the paper: early detection and treatment of osteoporosis may reduce dementia risk.</p><p><strong>Purpose: </strong>Dementia and osteoporosis share common risk factors and are increasing in prevalence in the aging population. This study aimed to investigate the impact of osteoporosis on dementia and its subtypes in women using data from a population-based, health-screening cohort, with a follow-up period of more than 10 years.</p><p><strong>Methods: </strong>This retrospective study included 66-year-old Korean women who participated in the \"National Screening Program for Transitional Ages\" from 2010 to 2011. Participants were categorized based on spine bone mineral density T-scores into three groups: normal (T-score ≥ - 1.0 standard deviation [SD]; 18.7%), osteopenia (- 2.5 SD < T-score < - 1.0 SD; 42.5%), and osteoporosis (T-score ≤ - 2.5 SD; 38.8%). Incident dementia cases were evaluated until 2021 using national healthcare claims databases. Fine-Gray subdistribution hazard models were used to assess the risks of all-cause dementia including Alzheimer's disease (AD) dementia and vascular dementia (VaD), accounting for death as a competing risk.</p><p><strong>Results: </strong>The study included 131,872 dementia-free women aged 66 years. Over an average follow-up of 10.4 ± 1.8 years, 9399 individuals developed all-cause dementia (7.1%). Osteoporosis was associated with increased risks for all-cause dementia (adjusted subdistribution hazard ratio [asHR] 1.14; 95% confidence interval [CI] 1.08-1.21; p < 0.001), AD dementia (asHR 1.14; 95% CI 1.08-1.22; p < 0.001), and VaD (asHR 1.42; 95% CI 1.08-1.87; p = 0.013), compared to normal.</p><p><strong>Conclusion: </strong>Our findings highlight an association between osteoporosis and increased risks of developing all-cause dementia, AD dementia, and VaD. Further research is needed to explore the effects of early identification and treatment of osteoporosis in preventing dementia.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144710555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence and predictors of residual back pain after percutaneous vertebral augmentation in osteoporotic vertebral compression fracture: a systematic review and meta analysis.","authors":"Fang Fei Lyu, Min Zhang, Yuan Fen Deng, Qian Liu, Qian Yang, Li Rong Xia","doi":"10.1007/s00198-025-07609-8","DOIUrl":"https://doi.org/10.1007/s00198-025-07609-8","url":null,"abstract":"<p><p>The incidence and predictors of residual back pain (RBP) following percutaneous vertebral augmentation (PVA) in osteoporotic vertebral compression fractures (OVCFs) remain unclear. This review aims to clarify these factors to guide clinical practice and enhance patient outcomes. Four English and three Chinese databases were systematically searched from their inception until June 1, 2024. Data were analyzed using Stata 16.0. Incidence rates of RBP were pooled from all included studies, and predictors identified in two or more studies were aggregated. Sensitivity analyses were conducted for stability and reliability. Meta-regression and subgroup analyses were conducted to explore the causes of heterogeneity, while Begg, Egger test, and funnel plots were used to assess publication bias. This meta-analysis included 27 studies with a total of 8,806 patients, found that the incidence rate of RBP in patients with OVCFs after PVA was 24.4% (95% CI: 19.5-29.3%). Seventeen predictors for RBP were identified, which included demographic and personal history factors, injury characteristics, and bone cement and postoperative factors. The most frequent predictor was low preoperative bone density (OR = 2.208, 95% CI: 2.018-2.415, p < 0.001), followed by thoracolumbar fascia injury (OR = 3.875, 95% CI: 2.752-5.457, p < 0.001) and maldistribution of bone cement (OR = 2.065, 95% CI: 1.728-2.467, p < 0.001). Fifteen risk factors and two protective factors for RBP were identified. These findings highlight the importance of thorough preoperative assessment and meticulous surgical technique in reducing the risk of RBP in patients with OVCFs undergoing PVA. This study conducted a systematic review and meta-analysis to explore the incidence and predictors of residual back pain (RBP) in patients with osteoporotic vertebral compression fractures (OVCFs) who had underwent percutaneous vertebral augmentation (PVA).The findings identified a total of fifteen risk factors and two protective factors associated with RBP. Specifically, low preoperative bone density, thoracolumbar fascia injury, and maldistribution of bone cement were revealed to be the most common predictors.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144693121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"OsteoStrong and bone health: a scoping review.","authors":"Ameya Kabra, Wendy B Katzman, Nancy E Lane, Lora M Giangregorio","doi":"10.1007/s00198-025-07614-x","DOIUrl":"https://doi.org/10.1007/s00198-025-07614-x","url":null,"abstract":"<p><strong>Purpose: </strong>Osteostrong proposes that exercise on proprietary machines once weekly for 10 minutes increases bone mineral density. Because OsteoStrong franchises are open/opening in multiple countries, healthcare providers must be able to answer questions about OsteoStrong's efficacy and safety. Our objective was to synthesize current research on the efficacy and safety of OsteoStrong for healthcare providers who must be able to answer patients' questions about OsteoStrong's efficacy and safety.</p><p><strong>Methods: </strong>We conducted a rapid scoping review with searches in five databases. We included studies in English involving OsteoStrong machines, in any population and using any comparator, that measured falls, fractures, or bone strength. Screening and data abstraction were completed by two independent reviewers using Covidence. We used tables and descriptive statistics to chart data.</p><p><strong>Results: </strong>The search resulted in 1388 studies and nine were included; five were abstracts or unpublished. Seven studies were observational studies (e.g., case study/series, non-randomized trial) and two were randomized trials comparing OsteoStrong to exercise. There were no randomized controlled trials comparing OsteoStrong to a control group. Most studies had small sample sizes and potential conflicts of interest. The two largest studies included individuals on concurrent anti-resorptive treatment. Two of the trials reported on fractures, falls, or adverse events. Most trials reported on bone mineral density (BMD) at the lumbar spine and proximal femur. Effects on BMD were inconsistent across trials.</p><p><strong>Conclusions: </strong>The research on OsteoStrong is mainly limited to small observational studies that are at risk of bias because of conflict of interest, imprecision, publication in a predatory journal, participants on anti-resorptive medications, or poor-quality research reporting. The effects of OsteoStrong on bone strength outcomes are inconsistent, and currently there is little data on safety of this intervention.</p>","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144684004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to the editor concerning \"The impact of a fracture liaison service with in‑hospital anti‑osteoporosis treatment on subsequent hip fracture and mortality rates-a single‑center retrospective study\".","authors":"Li Liu, Dazhi Li","doi":"10.1007/s00198-025-07433-0","DOIUrl":"https://doi.org/10.1007/s00198-025-07433-0","url":null,"abstract":"","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144661718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"LTE: from early gains to lasting outcomes-expanding ANP-led models for hip fracture recovery.","authors":"Abdul Moeez Awais, Mahad Zulfiqar Ali Langrial, Mustafa Saad, Muhammad Haseeb Choudhry","doi":"10.1007/s00198-025-07622-x","DOIUrl":"https://doi.org/10.1007/s00198-025-07622-x","url":null,"abstract":"","PeriodicalId":520737,"journal":{"name":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144639603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}